These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 28669620)
1. Prenatal Tdap immunization and risk of maternal and newborn adverse events. Layton JB; Butler AM; Li D; Boggess KA; Weber DJ; McGrath LJ; Becker-Dreps S Vaccine; 2017 Jul; 35(33):4072-4078. PubMed ID: 28669620 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Klein NP; Cheetham TC; Naleway A; Omer SB; Hambidge SJ; Lee GM; Jackson ML; McCarthy NL; DeStefano F; Nordin JD JAMA; 2014 Nov; 312(18):1897-904. PubMed ID: 25387187 [TBL] [Abstract][Full Text] [Related]
3. Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. Griffin JB; Yu L; Watson D; Turner N; Walls T; Howe AS; Jiang Y; Petousis-Harris H Vaccine; 2018 Aug; 36(34):5173-5179. PubMed ID: 30031662 [TBL] [Abstract][Full Text] [Related]
4. Predictors of Low Uptake of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Immunization in Privately Insured Women in the United States. Butler AM; Layton JB; Li D; Hudgens MG; Boggess KA; McGrath LJ; Weber DJ; Becker-Dreps S Obstet Gynecol; 2017 Apr; 129(4):629-637. PubMed ID: 28277354 [TBL] [Abstract][Full Text] [Related]
5. Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations. Sukumaran L; McCarthy NL; Kharbanda EO; McNeil MM; Naleway AL; Klein NP; Jackson ML; Hambidge SJ; Lugg MM; Li R; Weintraub ES; Bednarczyk RA; King JP; DeStefano F; Orenstein WA; Omer SB JAMA; 2015 Oct; 314(15):1581-7. PubMed ID: 26501534 [TBL] [Abstract][Full Text] [Related]
6. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS; MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S. Becker-Dreps S; Butler AM; McGrath LJ; Boggess KA; Weber DJ; Li D; Hudgens MG; Layton JB Am J Prev Med; 2018 Aug; 55(2):159-166. PubMed ID: 29910115 [TBL] [Abstract][Full Text] [Related]
8. Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort study. Fakhraei R; Crowcroft N; Bolotin S; Sucha E; Hawken S; Wilson K; Gaudet L; Amirthalingam G; Biringer A; Cook J; Dubey V; Halperin SA; Jamieson F; Kwong JC; Sadarangani M; Walker MC; Laverty M; Fell DB CMAJ Open; 2021; 9(2):E349. PubMed ID: 33849984 [TBL] [Abstract][Full Text] [Related]
9. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Healy CM; Rench MA; Baker CJ Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585 [TBL] [Abstract][Full Text] [Related]
10. Maternal and infant outcomes among women vaccinated against pertussis during pregnancy. Berenson AB; Hirth JM; Rahman M; Laz TH; Rupp RE; Sarpong KO Hum Vaccin Immunother; 2016 Aug; 12(8):1965-1971. PubMed ID: 27002930 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults. Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial. Perrett KP; Halperin SA; Nolan T; Martínez Pancorbo C; Tapiero B; Martinón-Torres F; Stranak Z; Virta M; Vanderkooi OG; Kosina P; Encinas Pardilla MB; Cristobal García I; Zuccotti GV; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Marcos Fernández M; Rodríguez Zambrano MÁ; Martín García A; Asenjo de la Fuente JE; Camacho Marín MD; de la Calle Fernández-Miranda M; Romero Espinar Y; Marchisio PG; Manzoni P; Mesaros N Vaccine; 2020 Feb; 38(8):2095-2104. PubMed ID: 31776029 [TBL] [Abstract][Full Text] [Related]
13. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study. Abu Raya B; Srugo I; Kessel A; Peterman M; Bader D; Gonen R; Bamberger E Vaccine; 2014 Oct; 32(44):5787-93. PubMed ID: 25173476 [TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women. Villarreal Pérez JZ; Ramírez Aranda JM; de la O Cavazos M; Zamudio Osuna MJ; Perales Dávila J; Ballesteros Elizondo MR; Gómez Meza MV; García Elizondo FJ; Rodríguez González AM Hum Vaccin Immunother; 2017 Jan; 13(1):128-135. PubMed ID: 27686182 [TBL] [Abstract][Full Text] [Related]
15. Maternal Tdap vaccination and risk of infant morbidity. DeSilva M; Vazquez-Benitez G; Nordin JD; Lipkind HS; Klein NP; Cheetham TC; Naleway AL; Hambidge SJ; Lee GM; Jackson ML; McCarthy NL; Kharbanda EO Vaccine; 2017 Jun; 35(29):3655-3660. PubMed ID: 28552511 [TBL] [Abstract][Full Text] [Related]
16. Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women. Hall C; Abramovitz LM; Bukowinski AT; Ricker AA; Khodr ZG; Gumbs GR; Wells NY; Conlin AMS Vaccine; 2020 Feb; 38(8):1982-1988. PubMed ID: 31952872 [TBL] [Abstract][Full Text] [Related]
17. Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates. Morgan JL; Baggari SR; Chung W; Ritch J; McIntire DD; Sheffield JS Obstet Gynecol; 2015 Aug; 126(2):333-337. PubMed ID: 26241423 [TBL] [Abstract][Full Text] [Related]
18. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
19. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections. Khodr ZG; Bukowinski AT; Gumbs GR; Conlin AMS Vaccine; 2017 Oct; 35(42):5603-5610. PubMed ID: 28916245 [TBL] [Abstract][Full Text] [Related]
20. Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy. Tseng HF; Sy LS; Ackerson BK; Lee GS; Luo Y; Florea A; Becerra-Culqui T; Tartof SY; Tian Y; Taylor C; Campora L; Ceregido MA; Kuznetsova A; Poirrier JE; Rosillon D; Valdes L; Cheuvart B; Mesaros N; Meyer N; Guignard A; Qian L Vaccine; 2022 Jul; 40(32):4503-4512. PubMed ID: 35717267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]